Enteryx Procedure Kit Order No.: M00572600 -US and M00572500 -OUS
This recall has been terminated (originally issued October 28, 2005).
- Company
- Boston Scientific Corporation
- Recall Initiated
- September 23, 2005
- Posted
- October 28, 2005
- Terminated
- October 24, 2006
- Recall Number
- Z-0040-06
- Quantity
- M00572600 =7844 kits ;M00572500=859 kits
- Firm Location
- Natick, MA
- Official Source
- View on FDA website ↗
Reason for Recall
Incorrect implantation may cause serious health complications
Distribution
Nationwide :
Lot / Code Info
All codes
Root Cause
Other
Action Taken
Boston Scientific issued Recall notification by FED'X on 9/23/05 as follows Customers/ Hospital Account / Distributors: A Recall Notification Package will be sent to the risk manager of each hospital account via FedEx. This package contains a Recall Notification Letter, instructions on how to return product, a Recall Verification Form, and a Physician Letter that provides recommendations of patient follow-up. . Physicians Trained in the Enteryx Procedure: All physicians that attended the physician training program sent, via FedEx, a Physician Letter notifying them of the voluntary recall and providing them with firm recommendations on patient follow-up. In addition a copy of the Patient Letter and Patient Phone Script will be provided to assist in their communication to the patient. Patient Letter / Patient Phone Script: A letter and phone script, from the physician to the patient, will be provided to the physician to assist in the physician's communication to patient. The letter informs the patient of the recall and asks them to contact their physician and the Patient Phone Script provides a template to initiate a discussion with the patient. Physicians Participating in Post Approval Studies: All physicians that are participating in post approval studies will be sent, via FedEx, a Physician Letter notifying them of the voluntary recall and providing them with firm's recommendations on patient follow-up. In addition a copy of the Patient Letter and Patient Phone script will be provided to assist in their communication to the patient. Internal Review Boards (IRBs): All IRBs that are participating in post approval studies will be sent, via FedEx, a IRB Letter and the Physician Letter notifying them of the voluntary recall and providing them with firm's recommendations on patient follow-up. In addition a copy of the Patient Letter and Patient Phone Script will be provided. Boston Scientific has posted the recall to their website:http://www